Below are details of our Publishing Partners for 2017. We are indebted to their commitment to the African health sector, through their support towards the publication of Africa Health throughout the year.
LINET is a major European manufacturer of hospital and nursing beds. The company’s portfolio includes solutions designed for intensive care, products for regular in-bed treatment and also special beds for old people’s homes and long-term care facilities. The LINET range also includes a wide range of accessories such as anti-pressure ulcer mattresses, mobile equipment, healthcare furniture, etc.
LINET is maintaining its position out in front of its competitors in hospital bed manufacture. The firm regularly introduces products and services with innovative features and functions that reduce physical demands on staff, enhance the efficacy of care provided and increase patient comfort. LINET works intensively on developing such products in collaboration with healthcare professionals and respected experts in various scientific fields, enabling the firm to keep abreast of new trends in the area of medical care.
LINET headquarters, as well as its production plant, continue to be based in Czech Republic, where it has been located since its establishment in 1990. The plant manufactures around 90,000 hospital beds per year, the vast majority of which are intended for export to more than one hundred countries worldwide. LINET employs around 1500 staff. Since 2011, LINET has been a division of the multinational holding organisation LINET Group SE, with registered offices in the Netherlands.
Medicines for Malaria Venture (MMV) is recognized as the leading product development partnership (PDP) in the field of antimalarial drug research and development. It was established as a foundation in 1999 and registered in Switzerland. MMV’s mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. MMV’s vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.
Elizabeth Poll T +41 22 799 45 81
Medicines for Malaria Venture | MMV 20, route de Pré-Bois – PO Box 1826 1215 Geneva 15 – Switzerland
HemoCue is a global leader in a field of diagnostics known as near patient, or point-of-care, testing. In 1982, HemoCue AB, based in Ängelholm, Sweden, introduced the first system making accurate hemoglobin testing possible in near-patient settings. Since then, more than 350,000 HemoCue systems have been sold worldwide. The company also sells point-of-care tests for glucose, urine albumin, HbA1c, total and differential white blood cell count. HemoCue subsidiaries, affiliates, franchises, and third-party distributors generate revenue in more than 130 countries world wide. HemoCue was acquired by Radiometer, a Danaher company, in April 2013.
HMD is a market leader in the healthcare industry. HMD was founded in 1957 and is a closely held family Corporation. Its markets include Africa, India, USA, Europe, Middle East, and South East Asia. HMD has seven plants in different locations around South Asia and has more than 3500 employees. Their product range includes single use syringes, single use needles, I.V. cannulas, safety I.V. cannulas, surgical blades, scalpels, scalp vein sets, glass syringes, non-reusable (AD) syringes, blood collection tubes, blood collection needle, and blood collection set.